MedPath

Vitrectomy for Branch Retinal Vein Occlusion

Completed
Conditions
Vitrectomy
Interventions
Procedure: Vitrectomy w/o ILM peeling for macular edema with BRVO
Registration Number
NCT00685490
Lead Sponsor
Shinjo Ophthalmologic Institute
Brief Summary

To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occlusion (BRVO).

Results suggest the following hypothesis:

* PPV, with and without ILM peeling, appears to be beneficial in eyes with persistent macular edema due to BRVO

* Effectiveness is maintained long term

* ILM peeling does not significantly affect postoperative best corrected visual acuity (BCVA)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • duration of symptoms lasting 27 weeks
Exclusion Criteria
  • vitreous hemorrhage
  • severe cataract
  • biomicroscopic vitreomacular traction and epiretinal membrane
  • previous vitreoretinal surgery
  • other ocular diseases that could contribute to visual loss.
  • patients with macular branch vein occlusion
  • patients with a history of previous grid laser photocoagulation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SurgicalVitrectomy w/o ILM peeling for macular edema with BRVORetrospective chart review of 70 eyes of 70 consecutive patients who underwent PPV, with and without ILM peeling, for persistent macular edema associated with BRVO
Primary Outcome Measures
NameTimeMethod
Reporting of the long term outcomes of PPV, with and without ILM peeling, in eyes with persistent macular edema secondary to BRVO11 years
Secondary Outcome Measures
NameTimeMethod
Elevate the effectiveness of ILM peeling11 years

Trial Locations

Locations (1)

Shinjo Ophthalmologic Institute

🇯🇵

Miyazaki, Japan

© Copyright 2025. All Rights Reserved by MedPath